Статья

Novel therapeutic approaches for treatment of COVID-19

N. Hossein-khannazer, B. Shokoohian, A. Shpichka, H. Aghdaei, P. Timashev, M. Vosough,
2021

To date, there is no licensed treatment or approved vaccine to combat the coronavirus disease of 2019 (COVID-19), and the number of new cases and mortality multiplies every day. Therefore, it is essential to develop an effective treatment strategy to control the virus spread and prevent the disease. Here, we summarized the therapeutic approaches that are used to treat this infection. Although it seems that antiviral drugs are effective in improving clinical manifestation, there is no definite treatment protocol. Lymphocytopenia, excessive inflammation, and cytokine storm followed by acute respiratory distress syndrome are still unsolved issues causing the severity of this disease. Therefore, immune response modulation and inflammation management can be considered as an essential step. There is no doubt that more studies are required to clarify immunopathogenesis and immune response; however, new therapeutic approaches including mesenchymal stromal cell and immune cell therapy showed inspiring results. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • N. Hossein-khannazer
    Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • B. Shokoohian
    Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • A. Shpichka
    Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
  • H. Aghdaei
    Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • P. Timashev
    Institute for Regenerative Medicine, Sechenov University, Moscow, Russian Federation
  • M. Vosough
    Chemistry Department, Lomonosov Moscow State University, Moscow, Russian Federation
Название журнала
  • Journal of Molecular Medicine
Том
  • 98
Выпуск
  • 6
Страницы
  • 789-803
Ключевые слова
  • antivirus agent; BCG vaccine; corticosteroid; monoclonal antibody; phosphotransferase inhibitor; Janus kinase inhibitor; serine proteinase inhibitor; adoptive immunotherapy; coronavirus disease 2019; human; immune response; immunocompetent cell; immunomodulation; immunopathogenesis; immunotherapy; inflammation; mesenchymal stroma cell; nanomedicine; nonhuman; passive immunotherapy; Review; Betacoronavirus; Coronavirus infection; genetics; immunology; mesenchymal stem cell transplantation; pandemic; passive immunization; procedures; virology; virus pneumonia; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antiviral Agents; BCG Vaccine; Betacoronavirus; Coronavirus Infections; Humans; Immunization, Passive; Immunotherapy, Adoptive; Janus Kinase Inhibitors; Mesenchymal Stem Cell Transplantation; Nanomedicine; Pandemics; Pneumonia, Viral; Serine Proteinase Inhibitors
Издатель
  • Springer
Тип документа
  • Review
Источник
  • scopus